Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging in Prostate Cancer
NCT02840617Phase 1Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in prostate cancer (PCa), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Sensitivity and specificity of the ICG-based fluorescence to detect prostate cancer. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02840617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840617.